Page last updated: 2024-10-31

methyl salicylate and Cytokine Release Syndrome

methyl salicylate has been researched along with Cytokine Release Syndrome in 1 studies

methyl salicylate: used in over-the-counter liniments, ointments, lotions for relief of musculoskeletal aches and pains; has hemolytic effect on human & sheep erythrocytes; RN given refers to parent cpd; structure in Merck Index, 9th ed, #5990
methyl salicylate : A benzoate ester that is the methyl ester of salicylic acid.

Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, X1
Gong, N1
Tian, F1
Zhang, S1
Zhang, Y1
Wang, Y2
Qing, G1
Li, F1
Xu, Y1
Zhang, L1
Wang, J1
Ni, Q1
Gan, Y1
Gu, C1
Jiang, H1
Huang, X1
Shi, X1
Zhang, T1
Wu, Y1
Liang, XJ1

Other Studies

1 other study available for methyl salicylate and Cytokine Release Syndrome

ArticleYear
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel.
    Nature biomedical engineering, 2023, Volume: 7, Issue:9

    Topics: Animals; Antibodies, Neutralizing; Cell- and Tissue-Based Therapy; Cytokine Release Syndrome; Cytoki

2023